Growth Metrics

Thermo Fisher Scientific (TMO) Equity Average (2016 - 2025)

Historic Equity Average for Thermo Fisher Scientific (TMO) over the last 17 years, with Q3 2025 value amounting to $50.8 billion.

  • Thermo Fisher Scientific's Equity Average rose 533.76% to $50.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $50.8 billion, marking a year-over-year increase of 533.76%. This contributed to the annual value of $48.2 billion for FY2024, which is 611.68% up from last year.
  • According to the latest figures from Q3 2025, Thermo Fisher Scientific's Equity Average is $50.8 billion, which was up 533.76% from $50.0 billion recorded in Q2 2025.
  • In the past 5 years, Thermo Fisher Scientific's Equity Average registered a high of $50.8 billion during Q3 2025, and its lowest value of $34.8 billion during Q2 2021.
  • In the last 5 years, Thermo Fisher Scientific's Equity Average had a median value of $43.8 billion in 2022 and averaged $43.9 billion.
  • As far as peak fluctuations go, Thermo Fisher Scientific's Equity Average soared by 2306.53% in 2021, and later surged by 328.65% in 2023.
  • Over the past 5 years, Thermo Fisher Scientific's Equity Average (Quarter) stood at $39.8 billion in 2021, then increased by 10.15% to $43.8 billion in 2022, then grew by 5.07% to $46.0 billion in 2023, then increased by 7.03% to $49.3 billion in 2024, then grew by 3.02% to $50.8 billion in 2025.
  • Its Equity Average stands at $50.8 billion for Q3 2025, versus $50.0 billion for Q2 2025 and $49.5 billion for Q1 2025.